Could lower blood transfusion levels help leukemia patients?
NCT ID NCT06710418
Summary
This study is testing whether giving blood transfusions at a lower hemoglobin level (7 gm/dL) works as well as giving them at a higher level (9 gm/dL) for leukemia patients after chemotherapy or stem cell transplant. Researchers want to see if the lower level maintains patients' quality of life and function while reducing transfusion side effects and helping conserve limited blood supplies. The study involves 50 adult patients with certain types of leukemia who are receiving intensive treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.